Reduction of ischemic damage in NGF-transgenic mice:: Correlation with enhancement of antioxidant enzyme activities

被引:94
作者
Guégan, C [1 ]
Ceballos-Picot, I
Chevalier, E
Nicole, A
Onténiente, B
Sola, B
机构
[1] Univ Caen, CNRS, UMR 6551, Neurosci Lab, F-14074 Caen, France
[2] Hop Necker Enfants Malad, CNRS, URA 1335, F-75743 Paris 15, France
[3] UFR Med, INSERM, U421, IM3, F-94010 Creteil, France
[4] Univ Caen, UPRES EA 2128, Fac Med, F-14032 Caen, France
关键词
superoxide dismutase; glutathione metabolism; Bcl-2; family; nerve growth factor; transgenic mice; cerebral ischemia; apoptosis;
D O I
10.1006/nbdi.1999.0240
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
If permanent focal ischemia is induced by middle cerebral artery occlusion (MCAO), neurons within the infarcted territory die by necrosis and apoptosis (or programmed cell death). We have previously shown, using a mouse strain transgenic (tg) for the nerve growth factor (NGF) gene, that tg mice have consistently smaller infarcted areas than wild-type (wt) animals, correlated with upregulated NGF synthesis and impaired apoptotic cell death. We studied, in wt and tg mice subjected to MCAO, the activities of several antioxidant enzymes and the synthesis of the proteins of the Bcl-2 family. Our results show that the antiapoptotic Bcl-2 protein and glutathione peroxidase are recruited after MCAO. NGF-tg mice also had an intrinsic resistance to oxidative stress because their basal copper zinc superoxide dismutase (SOD) and glutathione transferase activities were high. Additionally, manganese SOD activity increased in NGF-tg mice after MCAO, correlating strongly with the resistance of these mice to apoptosis. (C) 1999 Academic Press.
引用
收藏
页码:180 / 189
页数:10
相关论文
共 36 条
[1]
Bcl-x1 bax interaction after transient global ischemia [J].
Antonawich, FJ ;
Krajewski, S ;
Reed, JC ;
Davis, JN .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (08) :882-886
[2]
Expression of interleukin-1 beta converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery [J].
Asahi, M ;
Hoshimaru, M ;
Uemura, Y ;
Tokime, T ;
Kojima, M ;
Ohtsuka, T ;
Matsuura, N ;
Aoki, T ;
Shibahara, K ;
Kikuchi, H .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (01) :11-18
[3]
DIFFERENTIAL LOCALIZATION OF GLUTATHIONE-S-TRANSFERASE YP-SUBUNIT AND YB-SUBUNIT IN OLIGODENDROCYTES AND ASTROCYTES OF RAT-BRAIN [J].
CAMMER, W ;
TANSEY, F ;
ABRAMOVITZ, M ;
ISHIGAKI, S ;
LISTOWSKY, I .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (03) :876-883
[4]
AGE-RELATED-CHANGES IN ANTIOXIDANT ENZYMES AND LIPID-PEROXIDATION IN BRAINS OF CONTROL AND TRANSGENIC MICE OVEREXPRESSING COPPER-ZINC SUPEROXIDE-DISMUTASE [J].
CEBALLOSPICOT, I ;
NICOLE, A ;
CLEMENT, M ;
BOURRE, JM ;
SINET, PM .
MUTATION RESEARCH, 1992, 275 (3-6) :281-293
[5]
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure [J].
CeballosPicot, I ;
WitkoSarsat, V ;
MeradBoudia, M ;
Nguyen, AT ;
Thevenin, M ;
Jaudon, MC ;
Zingraff, J ;
Verger, C ;
Jungers, P ;
DescampsLatscha, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 21 (06) :845-853
[6]
BRAIN INFARCTION IS NOT REDUCED IN SOD-1 TRANSGENIC MICE AFTER A PERMANENT FOCAL CEREBRAL-ISCHEMIA [J].
CHAN, PH ;
KAMII, H ;
YANG, GY ;
GAFNI, J ;
EPSTEIN, CJ ;
CARLSON, E ;
REOLA, L .
NEUROREPORT, 1993, 5 (03) :293-296
[7]
BCL-2 IS EXPRESSED IN NEURONS THAT SURVIVE FOCAL ISCHEMIA IN THE RAT [J].
CHEN, J ;
GRAHAM, SH ;
CHAN, PH ;
LAN, JQ ;
ZHOU, RL ;
SIMON, RP .
NEUROREPORT, 1995, 6 (02) :394-398
[8]
Chen J, 1996, J NEUROCHEM, V67, P64
[9]
The therapeutic potentials of neurotrophic factors for diseases of the nervous system [J].
Gao, WQ ;
Weil, RJ ;
DugichDjordjevic, M ;
Lu, B .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (04) :325-338
[10]
Altered expression of bcl-2, bcl-X, bax, and c-fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats [J].
Gillardon, F ;
Lenz, C ;
Waschke, KF ;
Krajewski, S ;
Reed, JC ;
Zimmermann, M ;
Kuschinsky, W .
MOLECULAR BRAIN RESEARCH, 1996, 40 (02) :254-260